Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in α₁-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population

This publication has 20 references indexed in Scilit:

• Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion
  Journal of Allergy and Clinical Immunology, 2001
• Risk of Hospital Admission for Obstructive Pulmonary Disease in α₁-Antitrypsin Heterozygotes of Phenotype PiMZ
  American Journal of Respiratory and Critical Care Medicine, 2000
• Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis
  Journal of Clinical Investigation, 1999
• Regulation of the serine proteinase inhibitor (SERPIN) gene α1-antitrypsin: A paradigm for other SERPINs
  The International Journal of Biochemistry & Cell Biology, 1997
• Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
  Published by Elsevier ,1997
• Longitudinal lung function study in heterozygous PiMZ phenotype subjects
  European Respiratory Journal, 1994
• Use of a Highly Purified α1-Antitrypsin Standard to Establish Ranges for the Common Normal and Deficient α1-Antitrypsin Phenotypes
  Chest, 1991
• DNA polymorphisms of the α₁ ‐antitrypsin gene region in patients with chronic obstructive pulmonary disease
  European Journal of Clinical Investigation, 1990
• RISK-FACTORS FOR OBSTRUCTIVE LUNG-DISEASE
  Published by Elsevier ,1981
• The PiMZ Phenotype: Is it a Significant Risk Factor for the Development of Chronic Obstructive Lung Disease?¹
  American Review of Respiratory Disease, 1978